Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
432M
-
Number of holders
-
264
-
Total 13F shares, excl. options
-
264M
-
Shares change
-
+1.84M
-
Total reported value, excl. options
-
$10.3B
-
Value change
-
+$68.2M
-
Put/Call ratio
-
0.1
-
Number of buys
-
170
-
Number of sells
-
-89
-
Price
-
$38.96
Significant Holders of Royalty Pharma plc - Common Stock (RPRX) as of Q1 2022
315 filings reported holding RPRX - Royalty Pharma plc - Common Stock as of Q1 2022.
Royalty Pharma plc - Common Stock (RPRX) has 264 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 264M shares
of 432M outstanding shares and own 61.06% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (53.5M shares), VANGUARD GROUP INC (31.9M shares), FMR LLC (28.2M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (24.8M shares), BlackRock Inc. (17.5M shares), VIKING GLOBAL INVESTORS LP (10.8M shares), STATE STREET CORP (7.76M shares), SIGULER GUFF ADVISERS, LLC (6.76M shares), JPMORGAN CHASE & CO (5.56M shares), and GEODE CAPITAL MANAGEMENT, LLC (5.01M shares).
This table shows the top 264 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.